HOME > Outline > Corporate Information
Corporate Information
As of October 1, 2009
Corporate Name MEDIPAL HOLDINGS CORPORATION
Head Office 2-7-15, Yaesu, Chuo-ku,
Tokyo 104-8461 Japan
Phone: 81-3-3517-5800
Founded October 8, 1898
Established May 6, 1923
Representative Sadatake Kumakura, President and Chief Executive Officer
Paid-in Capital 22,398 million yen (As of September 30, 2009)
Shares Outstanding 244,524,496 (As of September 30, 2009)
Stock Listing Tokyo Stock Exchange, First Section
Ticker Code 7459
Line of Business Control and supervision of operating companies and business development of the MEDIPAL Group as a pure holding company
Principal Shareholders

Takeda Pharmaceutical Company Limited, State Street Bank and Trust Company, Employees Shareholders' Association, Astellas Pharma Inc, Japan Trustee Services Bank, Ltd. (Trust Account), Eisai Co., Ltd., Daiichi Sankyo Co., Ltd., Kobayashi Pharmaceutical Co., Ltd., The Master Trust Bank of Japan, Ltd. (Trust Account), Japan Trustee Services Bank, Ltd. (Trust Account 9)

Notes: 1.  The Company holds 9,964 thousand shares of treasury stock, which are excluded from the major shareholders listed above.
2.  As of September 30, 2009
Employees 48
Fiscal Year End March 31
Main Banks Mizuho Bank, Ltd., Resona Bank, Limited, The Bank of Tokyo-Mitsubishi UFJ, Ltd., Sumitomo Mitsui Banking Corporation
page top